Events

Join us as the Symeres team embarks on a journey to the vibrant city of Tokyo for CPHI Japan 2024, taking place on April 17th, 18th, and 19th. We eagerly anticipate connecting with you at this premier event. Comprising our team are two notable individuals: Norimasa Morita, our Director of Business Development, and Eric Damen, our Director of Process Research. With fluency in English, Japanese, French, and Dutch, we break down language barriers to foster meaningful conversations. If you’re keen to explore Symeres’ extensive array of integrated drug discovery and development services, we invite you to schedule a meeting during the event. Reach out to Norimasa Morita via his LinkedIn profile to arrange a discussion. Let’s seize this opportunity to collaborate and innovate together!

Symeres is gearing up for the Swiss Biotech Days 2024. Catch us on April 22nd and 23rd at the Congress Center in Basel. Our Senior Vice President Drug Discovery Luc van Hijfte and our Business Development Director Karen Damian will be representing our organization. If you’re curious about Symeres’ extensive range of services and our holistic approach to supporting Pharma and Biotech clients, reach out to Karen Damian via LinkedIn to schedule a meeting. Rest assured, our team is as versatile as a Swiss Army knife, fluent in English, French, Italian, and Dutch!

Join our colleague Sascha Hartmann at the 35th Symposium on Medicinal Chemistry in Eastern England, taking place on April 25th in Stevenage. We are excited to witness the scientific presentations on cutting-edge topics at the forefront of drug discovery. Would you like to engage in scientific discussions and learn more about all the services Symeres has to offer? Stop by our booth; we’re available to assist you!

Symeres is happy to announce our participation in the CPHI North America conference, set to take place from May 7th to 9th, 2024, at Pennsylvania Convention Center, Philadelphia. We eagerly anticipate connecting with you at this premier event. Comprising our team are three notable individuals: Chris Teleha, our VP Business Development, CMC US, Yadan Chen, CEO, and Jay Patel, VP Pharmaceutical Science at Exemplify Biopharma / A Symeres Company. If you’re curious about Symeres’ extensive range of services and especially about drug substance and drug product development, reach out to Chris, Yadan, or Jay via LinkedIn to schedule a meeting. We are looking forward to connecting with industry leaders and experts. Be sure to visit our booth #410 to discover how our broad range of chemical services can support your projects. Our team will be on hand to answer any questions you may have, and to explore potential collaborations.

Symeres warmly extends an invitation to you to visit our booth (G32) at the BIO KOREA conference in Seoul, taking place from May 8th to May 10th, 2024. Representing our organization will be Russell Thomas, our Head of Business Development, and Laszlo Szilagyi, our Business Development Director, along with Francesca Dejure from our partner Axxam. Should you wish to delve further into Symeres’ extensive service portfolio of stand-alone and integrated solutions for Pharma and Biotech clients, we encourage you to contact Laszlo Szilagyi (Laszlo.Szilagyi@Symeres.com) to arrange a meeting in advance.

Organix, a Symeres company, will be present at TIDES USA 2024 in Boston, MA from 14-17 May (Booth 721). Our team for TIDES will consist of Organix co-founder and CEO Anu Mahadevan our VP of Business Development Chris Teleha, and our Director Yiliang Zhang. We warmly invite you to visit our booth when you want to discuss solutions involving lipids for LNPs Polymers, for PNPs and for GalNAc dendrimers, or any other drug discovery or development related support that you might need. Please contact Chris Teleha via his LinkedIn if you want to set up a meeting with one of our colleagues in Boston.

Symeres, Oncolines (A Symeres company), and Axxam will be present at Knowledge for Growth 2024 in Antwerp, Belgium from May 15th to 16th. The team will consist of Luc van Hijfte, Senior VP Drug Discovery, Kirill Kulish, business development scientist at Symeres, Dimitri Pappaioannou, Director of Business Development at Oncolines, and Atf Nagbou, Director of Business Development at Axxam. If you’re curious about Symeres’ and extensive range of services and especially about integrated drug discovery and drug development, reach out to Luc or Kirill. For questions regarding proliferation assays, combination studies or mechanistic cell biology, please, send PM to Dimitri. If you are interested in HTS and assay development, please, contact Atf. We eagerly anticipate networking with industry leaders and experts. Make sure to stop by our booth to explore how our extensive array of chemical, ADME and biology services can boost your projects. Our team will be available to address any inquiries and discuss potential collaborations.